Quest Diagnostics…
USUSDQuest Diagnostics Incorporated (US:DGX) — Medical Specialities. Количество бирж, на которых торгуются акции компании: 2. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- questdiagnostics.com
- Взаимодействие с инвесторами
- ir.questdiagnostics.com/overview/default.aspx
- Сектор
- Health Care · Medical Specialities
- Штаб-квартира
- Madison, United States
- Генеральный директор
- Steve Rusckowski
- Сотрудники
- 46 000
- Основана
- 1967
- Акций в обращении
- 110.37 млн на 2026-07-15
- Свободное обращение
- 109.81 млн
- Рыночная капитализация
- 25.21 млрд USD
- Инсайдеры
- 0.43%
- Институциональные инвесторы
- 98.9%
- Отрасль (SIC)
- Services-Medical Laboratories
- LEI
- 8MCWUBXQ0WE04KMXBX50
- Коэффициент выплат
- 34.2%
- FCF
- 1.35 млрд USD27%
- Долг
- 5.64 млрд USD3.7 г. FCF
- Стаж дивидендов
- 22 г.
- Прибыль, FCF и выплаченные дивиденды — за 12 месяцев до 30.06.2026 (последний отчёт компании).
Описание
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Дивиденды
Quest Diagnostics Incorporated (DGX) выплачивает дивиденды ежеквартально. За последние 12 месяцев за акцию было выплачено 3.38 USD (платежи: 4). Это примерно 1.46% от текущей цены акции. По истории выплат следующая экс-дивидендная дата ожидается около 05.01.2027. Лет непрерывных дивидендов: 22.
| Экс-дата | Выплата | Сумма | % | Тип | Тикер |
|---|---|---|---|---|---|
| 2026-10-06 | 2026-10-21 | 0.8600 USD | 0.4/1.5 % | ежеквартально | US:DGX |
| 2026-07-08 | 2026-07-22 | 0.8600 USD | 0.4/1.4 % | ежеквартально | US:DGX |
| 2026-04-06 | 2026-04-20 | 0.8600 USD | 0.4/1.4 % | ежеквартально | US:DGX |
| 2026-01-13 | 2026-01-28 | 0.8000 USD | 0.3/1.4 % | ежеквартально | US:DGX |
| 2025-10-03 | 2025-10-20 | 0.8000 USD | 0.3/≈1.4 % | ежеквартально | US:DGX |
| 2025-07-07 | 2025-07-21 | 0.8000 USD | 0.3/≈1.4 % | ежеквартально | US:DGX |
| 2025-04-07 | 2025-04-21 | 0.8000 USD | 0.3/≈1.4 % | ежеквартально | US:DGX |
Новости этой недели
Новостей с сайта компании пока нет.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| Blackrock Inc. | 8.4% | 9.28 млн | 2026-06-30 |
| Vanguard Capital Managem… | 6.55% | 7.23 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.55% | 6.13 млн | 2026-06-30 |
| State Street Corporation | 5% | 5.52 млн | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.93% | 5.44 млн | 2026-06-30 |
| Boston Partners | 4.3% | 4.74 млн | 2026-06-30 |
| JPMORGAN CHASE & CO | 3.19% | 3.52 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.51 млн | 2026-06-30 |
| Geode Capital Management… | 2.84% | 3.14 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 2.87 млн | 2026-06-30 |
| Morgan Stanley | 2.23% | 2.46 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.17% | 2.4 млн | 2026-06-30 |
| Edgepoint Investment Gro… | 2.04% | 2.25 млн | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 1.47 млн | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 1.43 млн | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 1.36 млн | 2026-08-31 |
| John Hancock Funds III-D… | 1.09% | 1.2 млн | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 1.04% | 1.15 млн | 2026-06-30 |
| T. Rowe Price Dividend G… | 1% | 1.11 млн | 2026-06-30 |
| John Hancock Funds III-D… | 0.96% | 1.06 млн | 2026-07-31 |
| DAVIS J E CAUSEY (Chief… | ≈0.13% | 142 423 | 2026-03-04 |
| DAVIS JAMES E (Chief Exe… | ≈0.11% | 122 423 | 2026-09-01 |
| DOHERTY CATHERINE T (Off… | ≈0.06% | 71 624 | 2026-03-05 |
| PREVOZNIK MICHAEL E (Gen… | ≈0.04% | 42 337 | 2026-08-28 |
| DEPPE MICHAEL J (Officer… | ≈0.03% | 35 196 | 2026-03-04 |
| SAMAD SAMER ABDUL (Chief… | ≈0.03% | 33 478 | 2026-07-22 |
| RING TIMOTHY M (Director… | ≈0.03% | 31 140 | 2026-05-20 |
| PFEIFFER GARY M (Directo… | ≈0.03% | 31 005 | 2026-05-20 |
| MAIN TIMOTHY L (Director… | ≈0.02% | 27 460 | 2026-07-22 |
| GREGG VICKY B (Director) | ≈0.02% | 18 386 | 2026-07-22 |
